December Public Offerings: Biotechs and EV Company Report
Read, Watch or Listen
United States. Several companies announced or completed public equity offerings this week. On Dec. 9 Terns Pharmaceuticals filed for a proposed $400 million offering with a 30-day option for $60 million, and Denali Therapeutics filed for a $200 million offering with a $30 million option. On Dec. 11 Blink Charging priced 26,666,666 shares at $0.75 raising about $20 million, Tenaya Therapeutics filed to offer units, and on Dec. 11 Terns and Dyne Therapeutics closed upsized offerings raising roughly $747.5 million and $402.5 million respectively. Underwriters and SEC filings accompanied the announcements. Based on 7 articles reviewed independently and supporting research.
Prepared by Christopher Adams and reviewed by editorial team.
Timeline of Events
- Dec. 9, 2025 — Terns announces proposed $400M offering and $60M option.
- Dec. 9, 2025 — Denali Therapeutics announces proposed $200M offering and $30M option.
- Dec. 10, 2025 — SEC declares Blink Charging registration effective (Form S-1).
- Dec. 11, 2025 — Blink prices 26,666,666 shares at $0.75 per share.
- Dec. 11, 2025 — Terns and Dyne close offerings, reporting $747.5M and $402.5M gross proceeds.
- Articles Published:
- 7
- Right Leaning:
- 0
- Left Leaning:
- 0
- Neutral:
- 7
- Distribution:
- Left 0%, Center 100%, Right 0%
Companies including Terns, Dyne, Denali, Blink Charging and Tenaya benefited by raising capital to finance research, clinical trials, manufacturing, working capital and EV network expansion, extending operational runway and enabling near-term program and infrastructure activities.
Existing common shareholders experienced potential dilution risk as companies issued common shares, pre-funded warrants and units, increasing outstanding share counts and potentially reducing per-share ownership and future earnings per share.
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Center
December Public Offerings: Biotechs and EV Company Report
Taiwan News Benzinga Taiwan News Taiwan News Taiwan News Taiwan News Taiwan NewsFrom Right
No right-leaning sources found for this story.
Comments